BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9495198)

  • 1. Evaluation and interference study of hemoglobin A1c measured by turbidimetric inhibition immunoassay.
    Chang J; Hoke C; Ettinger B; Penerian G
    Am J Clin Pathol; 1998 Mar; 109(3):274-8. PubMed ID: 9495198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an immunoturbidimetric assay for haemoglobin A1c on a Cobas Mira S analyser.
    Weets I; Gorus FK; Gerlo E
    Eur J Clin Chem Clin Biochem; 1996 May; 34(5):449-53. PubMed ID: 8790983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of three assay systems for automated determination of hemoglobin A1c.
    Halwachs-Baumann G; Katzensteiner S; Schnedl W; PĆ¼rstner P; Pieber T; Wilders-Truschnig M
    Clin Chem; 1997 Mar; 43(3):511-7. PubMed ID: 9068596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a fully automated high-performance liquid chromatography assay for hemoglobin A1c.
    Khuu HM; Robinson CA; Goolsby K; Hardy RW; Konrad RJ
    Arch Pathol Lab Med; 1999 Sep; 123(9):763-7. PubMed ID: 10458820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of turbidimetric inhibition immunoassay (TINIA) and HPLC methods for glycated haemoglobin determination.
    Genc S; Omer B; Aycan-Ustyol E; Ince N; Bal F; Gurdol F
    J Clin Lab Anal; 2012 Nov; 26(6):481-5. PubMed ID: 23143632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative measurement of HbA1c by an immunoturbidimetric assay compared to a standard HPLC method.
    Hamwi A; Schweiger CR; Veitl M; Schmid R
    Am J Clin Pathol; 1995 Jul; 104(1):89-95. PubMed ID: 7611190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of Hb A1c in chronic renal failure. Contribution of new methodologies].
    Flory E; Marzullo C; Bourderont D; Genestier S; Marichal B; Parent X
    Ann Biol Clin (Paris); 1996; 54(5):211-4. PubMed ID: 8869361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Falsely elevated hemoglobin A1c due to S-beta+-thalassemia interference in Bio-Rad Variant II Turbo HbA1c assay.
    Zhu Y; Williams LM
    Clin Chim Acta; 2009 Nov; 409(1-2):18-20. PubMed ID: 19698705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HbE and HbH on HbA1C level by ionic exchange HPLC comparing to immunoturbidimetry.
    Pravatmuang P; Sae-Ngow B; Whanpuch T; Leowattana W
    Clin Chim Acta; 2001 Nov; 313(1-2):171-8. PubMed ID: 11694256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Menarini-Arkray HA 8140 hemoglobin A1c analyzer.
    John WG; Braconnier F; Miedema K; Aulesa C; Piras G
    Clin Chem; 1997 Jun; 43(6 Pt 1):968-75. PubMed ID: 9191548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hemoglobin variants HbJ Bangkok, HbE, HbG Taipei, and HbH on analysis of glycated hemoglobin via ion-exchange high-performance liquid chromatography.
    Zhang XM; Wen DM; Xu SN; Suo MH; Chen YQ
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28407371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hemoglobin variants on hemoglobin a1c values measured using a high-performance liquid chromatography method.
    Lorenzo-Medina M; De-La-Iglesia S; Ropero P; Nogueira-Salgueiro P; Santana-Benitez J
    J Diabetes Sci Technol; 2014 Nov; 8(6):1168-76. PubMed ID: 25355712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical performance evaluation of the Mindray enzymatic assay for hemoglobin A
    Li M; Wu X; Xie W; Zeng Y; Wang H; Chen H; Xu A; Liu H; Ji L
    Sci Rep; 2024 May; 14(1):12289. PubMed ID: 38811684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of HbA1c using different methods in haemoglobin variant, Hb J-Bangkok].
    Sawaragi W; Shibuya H; Yasuda K; Suzuki H; Shimizu C; Matsuno K
    Rinsho Byori; 2009 May; 57(5):431-5. PubMed ID: 19522248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of rare hemoglobin variants by hemoglobin A
    Strickland SW; Campbell ST; Little RR; Bruns DE; Bazydlo LAL
    Clin Chim Acta; 2018 Jan; 476():67-74. PubMed ID: 29154790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in HbA1c Analysis and Reporting in Patients with Variant Hemoglobins.
    Sultana TA; Sheme ZA; Sultana GS; Sultana B; Mishu FA; Khan NZ; Sarkar BC; Muttalib MA; Khan SA; Choudhury S; Mahtab H
    Mymensingh Med J; 2016 Apr; 25(2):248-54. PubMed ID: 27277356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent hemoglobin variants and determination of HbA(1c) with the high-resolution program of the HPLC HA-8160 hemoglobin analyzer.
    Schnedl WJ; Lahousen T; Wallner SJ; Krause R; Lipp RW
    Clin Biochem; 2005 Jan; 38(1):88-91. PubMed ID: 15607323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of the Hope Hemoglobin With Hemoglobin A1c Results.
    Chakraborty S; Chanda D; Gain M; Krishnan P
    Lab Med; 2015; 46(3):221-5. PubMed ID: 26199262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta thalassemia minor on results of six glycated hemoglobin methods.
    Polage C; Little RR; Rohlfing CL; Cole TG; Roberts WL
    Clin Chim Acta; 2004 Dec; 350(1-2):123-8. PubMed ID: 15530468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Hb A1c Quantification in the Presence of Hemoglobin Variants of an HPLC Assay with an Enzymatic Assay.
    Nichols JH; Berman M; Carrillo A; Manning S
    J Appl Lab Med; 2023 Nov; 8(6):1127-1132. PubMed ID: 37610380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.